Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development Perspective.
Saved in:
| Title: | Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development Perspective. |
|---|---|
| Authors: | Krishna R; Certara Drug Development Solutions, Certara USA, Inc., Radnor, Pennsylvania, USA., Suryawanshi S; Bristol-Myers Squibb, Princeton, New Jersey, USA., Rascher J; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Hartmann S; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA., Sebastien B; Sanofi, R&D, Gentilly, France., Barrett JS; Aridhia Bioinformatics, Glasgow, UK. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Dec; Vol. 118 (6), pp. 1276-1285. Date of Electronic Publication: 2025 Apr 16. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1532-6535 |
|---|---|
| DOI: | 10.1002/cpt.3683 |
